Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022

Date: October 12, 2017
Pages: 227
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: EC412F418BAEN
Leaflet:

Download PDF Leaflet

Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022
“The Global Epigenetics Market Is Projected to Register a CAGR of 13.5% During the Forecast Period (2017–2022).”

The global epigenetics market is projected to reach USD 1,605.7 million by 2022 from USD 854.0 million in 2017, at a CAGR of 13.5% during the forecast period. The decreasing sequencing costs and time, increasing research activities, favorable funding scenario for epigenetics research, rising prevalence of cancer are the key factors driving market growth during the forecast period. On the other hand, the high cost of instruments is expected to restrain the growth of this market to a certain extent.

“Oncology Segment Dominated the Global Epigenetics Market, by Application, in 2016”

On the basis of application, the epigenetics market is segmented into oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications (includes neurology, gynecology, and infectious diseases). In 2016, the oncology segment accounted for the major share of the global epigenetics market. The large share of this segment is attributed to the rising prevalence of cancer and the increasing number of research-related activities.

“Pharmaceutical and Biotechnology Companies to Register the Highest Growth Rate During the Forecast Period”

On the basis of end users, the epigenetics market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). The pharmaceutical and biotechnology companies segment is expected to register the highest CAGR during the forecast period, owing to increasing research in the areas of genomics with a strong focus on personalized medicine.

“APAC to Witness the Highest Growth Rate During the Forecast Period”

The global epigenetics market is broadly segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. North America accounted for the largest share of the global epigenetics market in 2016, while Asia Pacific is projected to register the highest growth rate during the forecast period. Factors such as increasing R&D spending, favorable government initiatives, and rising focus of key market players on enhancing their presence in this region are supporting the growth of the epigenetics market in the Asia Pacific.

The breakup of primary participants has been mentioned below:
  • By Company Type – Tier 1: 35%, Tier 2–40% and Tier 3–25%
  • By Designation – C Level: 33%, Director Level: 41%, Others: 26%
  • By Region – North America: 35%, Europe: 30%, Asia Pacific: 21%, and RoW: 14%
The prominent players in the epigenetics market include Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-Rad (US).

Research Coverage:

The report aims at estimating the market size and future growth potential of the epigenetics market for different segments such as product, application, technology, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned strategies for strengthening their market positions.

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the epigenetics market
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the epigenetics market
  • Market Development: Comprehensive information about lucrative emerging markets, by product, application, technology, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the epigenetics market
  • Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the epigenetics market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH APPROACH
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Key Data from Primary Sources
    2.1.2.2 Key Industry Insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 EPIGENETICS MARKET: OVERVIEW
4.2 EPIGENETICS MARKET: DEVELOPED VS DEVELOPING COUNTRIES
4.3 GEOGRAPHIC SNAPSHOT: EPIGENETICS MARKET (2016)
4.4 GEOGRAPHIC MIX: EPIGENETICS MARKET
4.5 APAC: EPIGENETICS MARKET, BY TECHNOLOGY
4.6 EPIGENETICS KITS MARKET SIZE, BY TYPE (2017 VS. 2022)

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 KEY MARKET DYNAMICS
  5.2.1 MARKET DRIVERS
    5.2.1.1 Declining sequencing costs and time
    5.2.1.2 Increasing research activities and availability of government funding
    5.2.1.3 Rising cancer prevalence
  5.2.2 MARKET RESTRAINTS
    5.2.2.1 High cost of instruments
  5.2.3 MARKET OPPORTUNITIES
    5.2.3.1 High growth potential in emerging markets
    5.2.3.2 Growing applications of epigenetics in personalized medicine and targeted therapy
    5.2.3.3 Use of epigenetics in non-oncology applications
  5.2.4 MARKET CHALLENGES
    5.2.4.1 Dearth of trained professionals
    5.2.4.2 Concerns regarding the quality of antibodies

6 EPIGENETICS MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 KITS
  6.2.1 CHIP-SEQ KITS
  6.2.2 BISULFITE CONVERSION KITS
  6.2.3 WHOLE-GENOME AMPLIFICATION KITS
  6.2.4 5-HMC AND 5-MC ANALYSIS KITS
  6.2.5 RNA SEQUENCING KITS
  6.2.6 OTHER EPIGENETICS KITS
6.3 REAGENTS
  6.3.1 ANTIBODIES
  6.3.2 MAGNETIC BEADS
  6.3.3 HISTONES
  6.3.4 BUFFERS
  6.3.5 PRIMERS
  6.3.6 OTHER EPIGENETICS REAGENTS
6.4 ENZYMES
  6.4.1 DNA-MODIFYING ENZYMES
  6.4.2 PROTEIN-MODIFYING ENZYMES
  6.4.3 RNA-MODIFYING ENZYMES
6.5 INSTRUMENTS AND CONSUMABLES
  6.5.1 NEXT-GENERATION SEQUENCERS
  6.5.2 QPCR INSTRUMENTS
  6.5.3 MASS SPECTROMETERS
  6.5.4 SONICATORS
  6.5.5 OTHER INSTRUMENTS AND CONSUMABLES
6.6 BIOINFORMATICS TOOLS

7 EPIGENETICS MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 ONCOLOGY
7.3 METABOLIC DISEASES
7.4 DEVELOPMENTAL BIOLOGY
7.5 IMMUNOLOGY
7.6 CARDIOVASCULAR DISEASES
7.7 OTHER APPLICATIONS

8 EPIGENETICS MARKET, BY TECHNOLOGY

8.1 INTRODUCTION
8.2 DNA METHYLATION
8.3 HISTONE MODIFICATION
8.4 OTHER TECHNOLOGIES

9 EPIGENETICS MARKET, BY END USER

9.1 INTRODUCTION
9.2 ACADEMIC AND RESEARCH INSTITUTES
9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.4 CONTRACT RESEARCH ORGANIZATIONS

10 EPIGENETICS MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
  10.2.1 US
  10.2.2 CANADA
10.3 EUROPE
  10.3.1 GERMANY
  10.3.2 UK
  10.3.3 FRANCE
  10.3.4 ITALY
  10.3.5 SPAIN
  10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
  10.4.1 JAPAN
  10.4.2 CHINA
  10.4.3 INDIA
  10.4.4 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.6 MIDDLE EAST AND AFRICA

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS (2016)
11.3 COMPETITIVE SITUATIONS & TRENDS
  11.3.1 PRODUCT LAUNCHES & ENHANCEMENT
  11.3.2 ACQUISITIONS
  11.3.3 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
  11.3.4 EXPANSIONS
  11.3.5 OTHER DEVELOPMENTS

12 COMPANY PROFILES

(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*

12.1 ILLUMINA
12.2 THERMO FISHER SCIENTIFIC
12.3 MERCK MILLIPORE
12.4 ABCAM
12.5 ACTIVE MOTIF
12.6 BIO-RAD
12.7 NEW ENGLAND BIOLABS
12.8 AGILENT
12.9 QIAGEN
12.10 ZYMO RESEARCH
12.11 PERKINELMER
12.12 DIAGENODE

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS

LIST OF TABLES

Table 1 GLOBAL EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 2 GLOBAL EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 3 GLOBAL EPIGENETICS KITS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 4 GLOBAL CHIP-SEQ KITS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 5 GLOBAL BISULFITE CONVERSION KITS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 6 GLOBAL WHOLE-GENOME AMPLIFICATION KITS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 7 GLOBAL 5-HMC AND 5-MC ANALYSIS KITS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 8 GLOBAL RNA SEQUENCING KITS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 9 GLOBAL OTHER EPIGENETICS KITS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 10 GLOBAL EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 11 GLOBAL EPIGENETICS REAGENTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 12 GLOBAL ANTIBODIES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 13 GLOBAL MAGNETIC BEADS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 14 GLOBAL HISTONES MARKET, BY COUNTRY/REGION, 2015–2021 (USD MILLION)
Table 15 GLOBAL BUFFERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 16 GLOBAL PRIMERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 17 GLOBAL OTHER EPIGENETICS REAGENTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 18 GLOBAL EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 19 GLOBAL EPIGENETICS ENZYMES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 20 GLOBAL DNA-MODIFYING ENZYMES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 21 GLOBAL PROTEIN-MODIFYING ENZYMES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 22 GLOBAL RNA-MODIFYING ENZYMES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 23 GLOBAL EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 24 GLOBAL EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 25 GLOBAL NEXT-GENERATION SEQUENCERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 26 GLOBAL QPCR INSTRUMENTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 27 GLOBAL MASS SPECTROMETERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 28 GLOBAL SONICATORS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 29 GLOBAL OTHER INSTRUMENTS AND CONSUMABLES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 30 GLOBAL BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 31 GLOBAL EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 32 EPIGENOME-TARGETING CANCER DRUGS APPROVED OR IN CLINICAL TRIALS
Table 33 GLOBAL EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 34 GLOBAL EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 35 GLOBAL EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 36 GLOBAL EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 37 GLOBAL EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 38 GLOBAL EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 39 GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 40 GLOBAL DNA METHYLATION MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 41 GLOBAL HISTONE MODIFICATION MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 42 GLOBAL OTHER TECHNOLOGIES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 43 GLOBAL EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 44 GLOBAL EPIGENETICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 45 GLOBAL EPIGENETICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 46 GLOBAL EPIGENETICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 47 EPIGENETICS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 48 NORTH AMERICA: EPIGENETICS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 49 NORTH AMERICA: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 50 NORTH AMERICA: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 51 NORTH AMERICA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 52 NORTH AMERICA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 53 NORTH AMERICA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 54 NORTH AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 55 NORTH AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 56 NORTH AMERICA: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 57 US: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 58 US: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 59 US: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 60 US: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 61 US: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 62 US: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 63 US: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 64 US: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 65 CANADA: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 66 CANADA: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 67 CANADA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 68 CANADA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 69 CANADA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 70 CANADA: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 71 CANADA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 72 CANADA: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 73 EUROPE: EPIGENETICS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 74 EUROPE: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 75 EUROPE: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 76 EUROPE: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 77 EUROPE: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 78 EUROPE: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 79 EUROPE: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 80 EUROPE: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 81 EUROPE: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 82 GERMANY: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 83 GERMANY: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 84 GERMANY: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 85 GERMANY: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 86 GERMANY: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 87 GERMANY: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 88 GERMANY: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 89 GERMANY: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 90 UK: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 91 UK: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 92 UK: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 93 UK: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 94 UK: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 95 UK: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 96 UK: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 97 UK: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 98 FRANCE: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 99 FRANCE: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 100 FRANCE: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 101 FRANCE: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 102 FRANCE: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 103 FRANCE: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 104 FRANCE: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 105 FRANCE: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 106 ITALY: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 107 ITALY: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 108 ITALY: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 109 ITALY: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 110 ITALY: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 111 ITALY: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 112 ITALY: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 113 ITALY: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 114 SPAIN: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 115 SPAIN: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 116 SPAIN: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 117 SPAIN: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 118 SPAIN: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 119 SPAIN: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 120 SPAIN: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 121 SPAIN: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 122 ROE: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 123 ROE: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 124 ROE: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 125 ROE: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 126 ROE: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 127 ROE: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 128 ROE: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 129 ROE: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 130 ASIA PACIFIC: EPIGENETICS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 131 ASIA PACIFIC: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 132 ASIA PACIFIC: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 133 ASIA PACIFIC: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 134 ASIA PACIFIC: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 135 ASIA PACIFIC: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 136 ASIA PACIFIC: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 137 ASIA PACIFIC: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 138 ASIA PACIFIC: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 139 JAPAN: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 140 JAPAN: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 141 JAPAN: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 142 JAPAN: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 143 JAPAN: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 144 JAPAN: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 145 JAPAN: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 146 JAPAN: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 147 CHINA: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 148 CHINA: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 149 CHINA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 150 CHINA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 151 CHINA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 152 CHINA: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 153 CHINA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 154 CHINA: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 155 INDIA: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 156 INDIA: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 157 INDIA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 158 INDIA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 159 INDIA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 160 INDIA: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 161 INDIA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 162 INDIA: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 163 ROAPAC: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 164 ROAPAC: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 165 ROAPAC: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 166 ROAPAC: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 167 ROAPAC: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 168 ROAPAC: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 169 ROAPAC: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 170 ROAPAC: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 171 LATIN AMERICA: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 172 LATIN AMERICA: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 173 LATIN AMERICA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 174 LATIN AMERICA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 175 LATIN AMERICA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 176 LATIN AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 177 LATIN AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 178 LATIN AMERICA: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 179 MIDDLE EAST AND AFRICA: EPIGENETICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
Table 180 MIDDLE EAST AND AFRICA: EPIGENETICS KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 181 MIDDLE EAST AND AFRICA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 182 MIDDLE EAST AND AFRICA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 183 MIDDLE EAST AND AFRICA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 184 MIDDLE EAST AND AFRICA: EPIGENETICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 185 MIDDLE EAST AND AFRICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 186 MIDDLE EAST AND AFRICA: EPIGENETICS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 187 NEW PRODUCT LAUNCHES AND ENHANCEMENTS, 2014–2017
Table 188 ACQUISITIONS, 2014–2017
Table 189 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS, 2014–2017
Table 190 EXPANSIONS, 2014–2017
Table 191 OTHER DEVELOPMENTS, 2014–2017

LIST OF FIGURES

Figure 1 RESEARCH DESIGN
Figure 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 BOTTOM-UP APPROACH
Figure 4 TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 GLOBAL EPIGENETICS MARKET, BY PRODUCT, 2017 VS. 2022 (USD BILLION)
Figure 7 GLOBAL EPIGENETICS MARKET, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
Figure 8 GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY, 2017 VS. 2022 (USD BILLION)
Figure 9 GLOBAL EPIGENETICS MARKET, BY END USER, 2017 VS. 2022 (USD BILLION)
Figure 10 GEOGRAPHIC SNAPSHOT: EPIGENETICS MARKET
Figure 11 DECLINING SEQUENCING COSTS, INCREASING RESEARCH ACTIVITIES, AND RISING CANCER PREVALENCE—KEY MARKET DRIVERS
Figure 12 CHINA TO REGISTER HIGHEST GROWTH IN THE FORECAST PERIOD
Figure 13 US ACCOUNTED FOR THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2016
Figure 14 NORTH AMERICA TO DOMINATE THE EPIGENETICS MARKET DURING THE FORECAST PERIOD
Figure 15 DNA METHYLATION TECHNOLOGY COMMANDED THE LARGEST SHARE OF THE APAC EPIGENETICS MARKET IN 2016
Figure 16 CHIP-SEQ KITS DOMINATES THE EPIGENETICS KITS MARKET IN 2017 AND 2022
Figure 17 EPIGENETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 18 SEQUENCING COST PER GENOME, 2001–2015 (USD MILLION)
Figure 19 KITS SEGMENT TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2017
Figure 20 ONCOLOGY APPLICATION SEGMENT TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2017
Figure 21 DNA METHYLATION SEGMENT TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2017
Figure 22 ACADEMIC AND RESEARCH INSTITUTES END USER SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2017
Figure 23 EPIGENETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
Figure 24 NORTH AMERICA: EPIGENETICS MARKET SNAPSHOT
Figure 25 ASIA PACIFIC: EPIGENETICS MARKET SNAPSHOT
Figure 26 GLOBAL EPIGENETICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
Figure 27 ILLUMINA: COMPANY SNAPSHOT (2016)
Figure 28 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)
Figure 29 MERCK MILLIPORE: COMPANY SNAPSHOT (2016)
Figure 30 ABCAM: COMPANY SNAPSHOT (2016)
Figure 31 BIO-RAD: COMPANY SNAPSHOT (2016)
Figure 32 AGILENT: COMPANY SNAPSHOT (2016)
Figure 33 QIAGEN: COMPANY SNAPSHOT (2016)
Figure 34 PERKINELMER: COMPANY SNAPSHOT (2016)
Skip to top


Ask Your Question

Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: